skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors

de Braud, F. ; Cascinu, S. ; Spitaleri, G. ; Pilz, K. ; Clementi, L. ; Liu, D. ; Sikken, P. ; De Pas, T.

Annals of oncology, 2015-11, Vol.26 (11), p.2341-2346 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial
Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial

Passaro, A. ; Laktionov, K.K. ; Poltoratskiy, A. ; Egorova, I. ; Hochmair, M. ; Migliorino, M.R. ; Metro, G. ; Gottfried, M. ; Tsoi, D. ; Ostoros, G. ; Rizzato, S. ; Mukhametshina, G.Z. ; Schumacher, M. ; Novello, S. ; Dziadziuszko, R. ; Tang, W. ; Clementi, L. ; Cseh, A. ; Kowalski, D. ; De Marinis, F.

Annals of oncology, 2019-04, Vol.30, p.ii48-ii49 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Genetic Factors Associated with Platinum Toxicity: A Preliminary Study
Genetic Factors Associated with Platinum Toxicity: A Preliminary Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic Factors Associated with Platinum Toxicity: A Preliminary Study

De Troia, B. ; Davide, D. ; Filipazzi, V. ; Isabella, L. ; Tosca, N. ; Ferrario, S. ; Gambaro, A. ; Somma, L. ; Fasola, C. ; Pellegrini, I. ; Bombonati, G. ; Damiani, E. ; Cheli, S. ; Falvella, F.S. ; Clementi, E. ; de Francesco, D. ; Cattaneo, M.T.

Annals of oncology, 2017-10, Vol.28, p.vi95-vi95 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC
Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC

De Marinis, F. ; Laktionov, K.K. ; Poltoratskiy, A. ; Egorova, I. ; Hochmair, M. ; Passaro, A. ; Migliorino, M.R. ; Metro, G. ; Gottfried, M. ; Tsoi, D. ; Ostoros, G. ; Rizzato, S. ; Mukhametshina, G.Z. ; Schumacher, M. ; Novello, S. ; Dziadziuszko, R. ; Tang, W. ; Clementi, L. ; Cseh, A. ; Kowalski, D.

Annals of oncology, 2019-11, Vol.30, p.ix161-ix162 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
A phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFR mutation-positive NSCLC: A biomarker analysis
A phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFR mutation-positive NSCLC: A biomarker analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFR mutation-positive NSCLC: A biomarker analysis

Rosell, R. ; Poltoratskiy, A. ; Hochmair, M. ; Laktionov, K.K. ; Ramlau, R. ; Garcìa, M. Alonso ; Skrickova, J. ; Piovano, P.L. ; Rizzato, S. ; Bidoli, P. ; Kowalski, D. ; Clementi, L. ; Cseh, A. ; De Marinis, F.

Annals of oncology, 2019-11, Vol.30, p.ix162-ix163 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Afatinib in EGFR TKI-naïve patients with EGFR mutation-positive (EGFRm+) NSCLC: Interim analysis of a phase IIIb, multi-national, open-label study
Afatinib in EGFR TKI-naïve patients with EGFR mutation-positive (EGFRm+) NSCLC: Interim analysis of a phase IIIb, multi-national, open-label study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Afatinib in EGFR TKI-naïve patients with EGFR mutation-positive (EGFRm+) NSCLC: Interim analysis of a phase IIIb, multi-national, open-label study

de Marinis, F. ; Laktionov, K.K. ; Poltoratskiy, A. ; Egorova, I. ; Hochmair, M. ; Passaro, A. ; Migliorino, M.R. ; Metro, G. ; Gottfried, M. ; Tsoi, D. ; Ostoros, G. ; Rizzato, S. ; Mukhametshina, G.Z. ; Schumacher, M. ; Novello, S. ; Tang, W. ; Clementi, L. ; Cseh, A. ; Kowalski, D.M.

Annals of oncology, 2019-10, Vol.30, p.v598-v599 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
1472P - Afatinib in EGFR TKI-naïve patients with EGFR mutation-positive (EGFRm+) NSCLC: Interim analysis of a phase IIIb, multi-national, open-label study
1472P - Afatinib in EGFR TKI-naïve patients with EGFR mutation-positive (EGFRm+) NSCLC: Interim analysis of a phase IIIb, multi-national, open-label study
Material Type:
Artigo 		Adicionar ao Meu Espaço

1472P - Afatinib in EGFR TKI-naïve patients with EGFR mutation-positive (EGFRm+) NSCLC: Interim analysis of a phase IIIb, multi-national, open-label study

de Marinis, F. ; Laktionov, K.K. ; Poltoratskiy, A. ; Egorova, I. ; Hochmair, M. ; Passaro, A. ; Migliorino, M.R. ; Metro, G. ; Gottfried, M. ; Tsoi, D. ; Ostoros, G. ; Rizzato, S. ; Mukhametshina, G.Z. ; Schumacher, M. ; Novello, S. ; Tang, W. ; Clementi, L. ; Cseh, A. ; Kowalski, D.M.

Annals of oncology, 2019-10, Vol.30, p.v598-v599 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Activity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials
Activity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activity of afatinib in patients (pts) with NSCLC harboring uncommon EGFR mutations: Pooled analysis of three large phase IIIB trials

Passaro, A. ; De Marinis, F. ; Tu, H. ; Laktionov, K.K. ; Feng, J. ; Poltoratskiy, A. ; Zhao, J. ; Tan, E.-H. ; Gottfried, M. ; Lee, V. ; Kowalski, D. ; Yang, C.-T. ; Srinivasa, B. ; Clementi, L. ; Tang, W. ; Huang, D.C.-L. ; Cseh, A. ; Park, K. ; Zhou, C. ; Wu, Y.-L.

Annals of oncology, 2019-11, Vol.30, p.ix169-ix170 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Activity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials
Activity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Activity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials

Gottfried, M. ; de Marinis, F. ; Tu, H. ; Laktionov, K.K. ; Feng, J. ; Poltoratskiy, A. ; Zhao, J. ; Tan, E.-H. ; Lee, V. ; Kowalski, D. ; Yang, C.-T. ; Srinivasa, B. ; Passaro, A. ; Clementi, L. ; Tang, W. ; Huang, D.C.-L. ; Cseh, A. ; Park, K. ; Zhou, C. ; Wu, Y.-L.

Annals of oncology, 2019-11, Vol.30, p.ix163 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
A combined analysis of two phase IIIb studies of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC
A combined analysis of two phase IIIb studies of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC
Material Type:
Artigo 		Adicionar ao Meu Espaço

A combined analysis of two phase IIIb studies of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC

de Marinis, F. ; Tu, H. ; Laktionov, K.K. ; Feng, J. ; Poltoratskiy, A. ; Zhao, J. ; Egorova, I. ; Tan, E.-H. ; Gottfried, M. ; Lee, V. ; Kowalski, D.M. ; Yang, C.-T. ; Srinivasa, B.J. ; Passaro, A. ; Clementi, L. ; Tang, W. ; Huang, D C-L ; Cseh, A. ; Zhou, C. ; Wu, Y.-L.

Annals of oncology, 2019-10, Vol.30, p.v600 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.